Molecular regulation of hepatic fibrogenesis

Journal of Hepatology

Volumn 29, Issue 5, 1998, Pages 836-847

  Olaso, Elvira ^a   Friedman, Scott L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; INTEGRIN; MATRIX METALLOPROTEINASE;

APOPTOSIS; CELL PROLIFERATION; EXTRACELLULAR MATRIX; KUPFFER CELL; LIVER FIBROSIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW; STELLATE CELL; WOUND HEALING;

EID: 0032211577     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80269-9     Document Type: Review

References (134)

1. Gressner AM, Bachem MG. Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis. Semin Liver Dis. 10:1990;30-46.
2. Gressner AM, Bachem MG. Molecular mechanisms of liver fibrogenesis: a homage to the role of activated fat-storing cells. Digestion. 56:1995;335-346.
3. Senoo H, Imai K, Sato M, Kojima N, Miura M, Hata R. Three-dimensional structure of extracellular matrix reversibly regulates morphology, proliferation and collagen metabolism of perisinusoidal stellate cells (vitamin A-storing cells). Cell Biol Int. 20:1996;501-512.
4. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol. 127:1994;2037-2048. (2 Pt 2).
5. Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell DM. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem. 264:1989;10756-10762.
6. Bissell DM, Arenson DM, Maher JJ, Roll FJ. Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. J Clin Invest. 79:1987;801-812.
7. McGuire RF, Bissell DM, Boyles J, Roll FJ. Role of extracellular matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver. Hepatology. 15:1992;989-997.
8. Timpl R. Macromolecular organization of basement membranes. Curr Opin Cell Biol. 8:1996;618-624.
9. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science. 268:1995;233-239.
10. Scoazec JY. Expression of cell-matrix adhesion molecules in the liver and their modulation during fibrosis. J Hepatol. 22:1995;20-27. (Suppl).
11. Carloni V, Romanelli RG, Pinzani M, Laffi G, Gentilini P. Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. Gastroenterology. 110:1996;1127-1136.
12. Carloni V, Romanelli RG, Pinzani M, Laffi G, Gentilini P. Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. Gastroenterology. 112:1997;522-531.
13. Racine-Samson L, Rockey DC, Bissell DM. The role of alpha1beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture. J Biol Chem. 272:1997;30911-30917.
14. Imai K, Senoo H. Morphology of sites of adhesion between hepatic stellate cells (vitamin A-storing cells) and a three-dimensional extracellular matrix. Anat Rec. 250:1998;430-437.
15. Schuppan D, Schmid M, Somasundaram R, Ackermann R, Ruehl M, Nakamura T, et al. Collagens in the liver extracellular matrix bind hepatocyte growth factor. Gastroenterology. 114:1998;139-152.
16. Somasundaram R, Schuppan D. Type I, II, III, IV, V, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB). J Biol Chem. 271:1996;26884-26891.
17. Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. FASEB J. 11:1997;51-59.
18. Pinzani M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. Liver. 18:1998;2-13.
19. Shrivastava A, Radziejewski C, Campbell E, Kovac L, McGlynn M, Ryan TE, et al. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Molecular Cell. 1:1997;25-34.
20. Vogel W, Gish GD, Alves F, Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Molecular Cell. 1:1997;13-23.
21. Ankoma-Sey V, Matli M, Chang KB, Lalazar A, Donner DB, et al. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene. 1998;. in press.
22. Davis BH, Pratt BM, Madri JA. Retinol and extracellular collagen matrices modulate hepatic Ito cell collagen phenotype and cellular retinol binding protein levels. J Biol Chem. 262:1987;10280-10286.
23. Vyas SK, Leyland H, Gentry J, Arthur MJ. Rat hepatic lipocytes synthesize and secrete transin (stromelysin) in early primary culture. Gastroenterology. 109:1995;889-898.
24. Leyland H, Gentry J, Arthur MJ, Benyon RC. The plasminogen-activating system in hepatic stellate cells. Hepatology. 24:1996;1172-1178.
25. Takahara T, Furui K, Yata K, et al. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers. Hepatology. 26:1997;1521-1529.
26. Arthur MJ. Collagenases and liver fibrosis. J Hepatol. 22:1995;43-48. (Suppl).
27. Milani S, Herbst H, Schuppan D, et al. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol. 144:1994;528-537.
28. Herbst H, Wege T, Milani S, Pellegrini G, Orzechowski HD, Bechstein, et al. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol. 150:1997;1647-1659.
29. Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology. 110:1996;821-831.
30. Iredale JP, Goddard S, Murphy G, Benyon RC, Arthur MJ. Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci. 89:1995;75-81. (Colch).
31. Iredale JP, Benyon RC, Arthur MJ, Ferris WF, Alcolado R, Winwood, et al. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology. 24:1996;176-184.
32. Iredale JP. Tissue inhibitors of metalloproteinases in liver fibrosis. Int J Biochem Cell Biol. 29:1997;43-54.
33. Arthur MJ, Stanley A, Iredale JP, Rafferty JA, Hembry RM, Friedman SL. Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem J. 287:1992;701-707. (Pt 3).
34. Milani S, Herbst H, Schuppan D, Grappone C, Pellegrini G, et al. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol. 144:1994;528-537.
35. Poulos JE, Baldassare JJ, Bacon BR, Britton RS, Di Bisceglie AM, Bellezzo, et al. Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells. Am J Physiol. 273:1997;G804-G811. (Pt 1).
36. Theret N, Musso O, L'Helgoualc'h A, Clement B. Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interactions with hepatocytes. Am J Pathol. 150:1997;51-58.
37. Winwood PJ, Schuppan D, Iredale JP, Kawser CA, Docherty AJ, Arthur MJ. Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: characterization and expression in cultured cells. Hepatology. 22:1995;304-315.
38. Niki T, De Bleser PJ, Xu G, Van Den Berg K, Wisse E, Geerts A. Comparison of glial fibrillary acidic protein and desmin staining in normal and CCl4-induced fibrotic rat livers. Hepatology. 23:1996;1538-1545.
39. Ballardini G, Groff P, Badiali dGL, Schuppan D, Bianchi FB. Ito cell heterogeneity: desmin-negative Ito cells in normal rat liver. Hepatology. 19:1994;440-446.
40. Ramm GA, Britton RS, O'Neill R, Blaner WS, Bacor BR. Vitamin A-poor lipocytes: a novel desmin-negative lipocyte subpopulation, which can be activated to myofibroblasts. Am J Physiol. 269:1995;G532-G541. (Pt 1).
41. Niki T, Pekny M, Hellemans K, De Bleser P, Van den Berg K, Vaeyans F, et al. Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells. Hepatol. 1998;. in press.
42. Friedman SL. Hepatic stellate cells. Prog Liver Dis. 14:1996;101-130.
43. Gressner AM. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int Suppl. 54:1996;S39-S45.
44. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 328:1993;1828-1835.
45. Gressner AM. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol. 22:1995;28-36.
46. Houglum K, Venkataramani A, Lyche K, Chojkier M. A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C. Gastroenterology. 113:1997;1069-1073.
47. Paradis V, Kollinger M, Fabre M, Holstege A, Poynard T, Bedossa P. In situ detection of lipid peroxidation by-products in chronic liver diseases. Hepatology. 26:1997;135-142.
48. Paradis V, Mathurin P, Kollinger M, Imbert-Bismut F, Charlotte F, Piton A, et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol. 50:1997;401-406.
49. Leo MA, Rosman AS, Lieber CS. Differential depletion of carotenoids and tocopherol in liver disease. Hepatology. 17:1993;977-986.
50. Svegliati Baroni G, D'Ambrosio L, Ferretti G, Casini A, Di Sario A, Salzano R, et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology. 27:1998;720-726.
51. Montosi G, Garuti C, Martinelli S, Pietrangelo A. Hepatic stellate cells are not subjected to oxidant stress during iron-induced fibrogenesis. Hepatology. 27:1998;1611-1622.
52. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest. 96:1995;2461-2468.
53. Maher JJ, Tzagarakis C, Gimenez A. Malondialdehyde stimulates collagen production by hepatic lipocytes only upon activation in primary culture. Alcohol Alcohol. 29:1994;605-610.
54. Maher JJ, Neuschwander-Tetri BA. Manipulation of glutathione stores in rat hepatic stellate cells does not alter collagen synthesis. Hepatology. 26:1997;618-623.
55. Gleizes PE, Munger JS, Nunes I, Harpel JG, Mazzieri R, Noguera I, et al. TGF-beta latency: biological significance and mechanisms of activation. Stem Cells. 15:1997;190-197.
56. Hines JE, Johnson SJ, Burt AD. In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. Am J Pathol. 142:1993;511-518.
57. Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology. 11:1990;599-605.
58. Friedman SL, Arthur MJ. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J Clin Invest. 84:1989;1780-1785.
59. Enzan H, Himeno H, Iwamura S, Onishi S, Saibara T, Yamamoto Y, et al. Alpha-smooth muscle actin-positive perinusoidal stromal cells in human hepatocellular carcinoma. Hepatology. 19:1994;895-903.
60. Enzan H, Himeno H, Iwamura S, Saibara T, Onishi S, Yamamoto Y, et al. Sequential changes in human Ito cells and their relation to postnecrotic liver fibrosis in massive and submassive hepatic necrosis. Virchows Arch. 426:1995;95-101.
61. Olaso E, Santisteban A, Bidaurrazaga J, Gressner AM, Rosenbaum J, Vidal-Vanaclocha F. Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology. 26:1997;634-642.
62. Lalazar A, Wong L, Yamasaki G, Friedman SL. Early genes induced in hepatic stellate cells during wound healing. Gene. 195:1997;235-243.
63. Koritschoner NP, Bocco JL, Panzetta-Dutari GM, Dumur CI, Flury A, Patrito LC. A novel human zinc finger protein that interacts with the core promoter element of a TATA box-less gene. J Biol Chem. 272:1997;9573-9580.
64. Ratziu V, Lalazar A, Wong L, Dang Q, Collins C, Shaulian E, et al. Zf9, a Kruppel-like transcription factor upregulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci USA. 1998;. in press.
65. Kawada N, Uoya M, Seki S, Kuroki T, Kobayashi K. Regulation by cAMP of STAT1 activation in hepatic stellate cells. Biochem Biophys Res Commun. 233:1997;464-469.
66. Rippe RA, Almounajed G, Brenner DA. Sp1 binding activity increases in activated Ito cells. Hepatology. 22:1995;241-251.
67. Hernandez-Munoz I, de la Torre P, Sanchez-Alcazar JA, Garcia I, Santiago E, Munoz-Yague MT, et al. Tumor necrosis factor alpha inhibits collagen alpha 1(I) gene expression in rat hepatic stellate cells through a G protein. Gastroenterology. 113:1997;625-640.
68. Sprenger H, Kaufmann A, H Garn, Lahme B, Gemsa D, Gressner AM. Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. Gastroenterology. 113:1997;277-285.
69. Taub R. Blocking NF-kappaB in the liver: the good and bad news [editorial; comment]. Hepatology. 27:1998;1445-1446.
70. Hellerbrand C, Jobin C, Iimuro Y, Licato L, Sartor RB, Brenner DA. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super repressor [see comments]. Hepatology. 27:1998;1285-1295.
71. Hellerbrand, Wang SC, Tsukamoto H, Brenner DA, Rippe RA. Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology. 24:1996;670-676.
72. Baker SJ, Reddy EP. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene. 12:1996;1-9.
73. Naismith JH, Sprang SR. Modularity in the TNF-receptor family. Trends Biochem Sci. 23:1998;74-79.
74. Pinzani M, Milani S, Grappone C, Weber FJ, Gentilini P, Abbound HE. Expression of platelet-derived growth factor in a model of acute liver injury. Hepatology. 19:1994;701-707.
75. Wong L, Yamasaki G, Johnson RJ, Friedman SL. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest. 94:1994;1563-1569.
76. Marra F, Gentilini A, Pinzani M, Choudhury GG, Parola M, Herbst H, et al. Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells [see comments]. Gastroenterology. 112:1997;1297-1306.
77. Failli P, Ruocco C, De FR, Caligiuri A, Gentilini A, Giotti A, et al. The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx. Am J Physiol. 1995;C1133-C1139.
78. Di Sario A, Baroni GS, Bendia E, D'Ambrosio L, Ridolfi F, Marileo JR, et al. Characterization of ion transport mechanisms regulating intracellular pH in hepatic stellate cells. Am J Physiol. 273:1997;G39-G48. (Pt 1).
79. Nakamura T, Arii S, Monden K, Furutani M, Takeda Y, Imamura M, et al. Expression of the Na+/Ca2+ exchanger emerges in hepatic stellate cells after activation in association with liver fibrosis. Proc Natl Acad Sci USA. 95:1998;5389-5394.
80. Houglum K, Lee KS, Chojkier M. Proliferation of hepatic stellate cells is inhibited by phosphorylation of CREB on serine 133. J Clin Invest. 99:1997;1322-1328.
81. Rockey DC, Fouassier L, Chung JJ, Carayon A, Vallee P, Rey C, et al. Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology. 27:1998;472-480.
82. Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, et al. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology. 110:1996;534-548.
83. Kawada N, Kuroki T, Kobayashi K, Inoue M, Kaneda K, Decker K. Action of endothelins on hepatic stellate cells. J Gastroenterol. 30:1995;731-738.
84. Housset C, Rockey DC, Bissell DM. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci USA. 90:1993;9266-9270.
85. Mallat A, Preaux AM, Serradeil-Le Gal C, et al. Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors. J Clin Invest. 98:1996;2771-2778.
86. Marra F, Grandaliano G, Valente AJ, Abboud HE. Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1: potential role in liver injury. Hepatology. 22:1995;780-787.
87. Rosenbaum J, Blazejewski S, Preaux AM, Mallat A, Dhumeaux D, Mavier P. Fibroblast growth factor 2 and transforming growth factor beta 1 interactions in human liver myofibroblasts. Gastroenterology. 109:1995;1986-1996.
88. Skrtic S, Wallenius V, Ekberg S, Brenzel A, Gressner AM, Jansson JO. Insulin-like growth factors stimulate expression of hepatocyte growth factor but not transforming growth factor beta 1 in cultured hepatic stellate cells. Endocrinology. 138:1997;4683-4689.
89. Pinzani M, Abboud HE, Aron DC. Secretion of insulin-like growth factor-I and binding proteins by rat liver fat-storing cells: regulatory role in platelet-derived growth factor. Endocrinology. 127:1990;2343-2349.
90. Marra F, DeFranco R, Grappone C, Milani S, Pinzani M, Pellegrini G, et al. Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. Hepatology. 27:1998;462-471.
91. Reimann T, Hempel U, Krautwald S, Axmann A, Scheibe R, Seidel D, et al. Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett. 403:1997;57-60.
92. Ankoma-Sey V, Tzagarakis C, Chang KB, Friedman SL. Downregulation of matrix and beta-PDGF receptor gene expression by anti-TGFbeta antibody in rat hepatic stellate cells during experimental liver injury. Int Hepatol Comm. 6:1997;144-152.
93. Rosenbaum J, Blazejewski S. Regulation of Ito cell proliferation by soluble factors. J Hepatol. 22:1995;65-70. (Suppl).
94. Rockey DC. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology. 25:1997;2-5.
95. Rockey DC, Weisiger RA. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology. 24:1996;233-240.
96. Bauer M, Paquette NC, Zhang JX, I Bauer, Pannen BH, Kleeberger SR, et al. Chronic ethanol consumption increases hepatic sinusoidal contractile response to endothelin-1 in the rat. Hepatology. 22:1995;1565-1576.
97. Bataller R, Nicolas JP, Gines P, Esteve A, Nieve Gorbig M, Garcia-Ramallo, et al. Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells. Gastroenterology. 113:1997;615-624.
98. Kawada N, Klein H, Decker K. Eicosanoid-mediated contractility of hepatic stellate cells. Biochem J. 285:1992;367-371.
99. Kawada N, Inoue M. Effect of adrenomedullin on hepatic pericytes (stellate cells) of the rat. FEBS Lett. 356:1994;109-113.
100. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy [see comments]. N Engl J Med. 324:1991;933-940.
101. Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest. 96:1995;447-455.
102. Ratziu R, Kim SJ, Kim YS, Dang S, Wong L, Friedman SL. A key role for Zf9 in hepatic fibrosis via its transcriptional activation of TGFb1 and types I and II TGFb receptors genes in rat stellate cells. Hepatology. 26:1997;185A.
103. Gong W, Gressner AM, Michel K, Roth S. Isoforms and splice variant of transforming growth factor beta-binding protein in rat hepatic stellate cells. Gastroenterology. 114:1998;352-363.
104. Michel K, Roth S, Trautwein C, Gong W, Flemming P, Gressner AM. Analysis of the expression pattern of the latent transforming growth factor beta binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region. Hepatology. 27:1998;1592-1599.
105. Friedman SL, Yamasaki G, Wong L. Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo. J Biol Chem. 269:1994;10551-10558.
106. Armendariz-Borunda J, Katayama K, Seyer JM. Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1 beta, tumor necrosis factor alpha, and transforming growth factor beta in Ito cells. J Biol Chem. 267:1992;14316-14321.
107. Armendariz-Borunda J, Simkevich CP, Roy N, Raghow R, Kang AH, Seyer JM. Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem J. 304:1994;817-824. (Pt 3).
108. Brenner DA, Westwick J, Breindl M. Type I collagen gene regulation and the molecular pathogenesis of cirrhosis. Am J Physiol. 264:1993;G589-G595. (Pt 1).
109. Nehls MC, Rippe RA, Veloz L, Brenner DA. Transcription factors nuclear factor I and Sp1 interact with the murine collagen alpha 1 (I) promoter. Mol Cell Biol. 11:1991;4065-4073.
110. Inagaki Y, Truter S, Greenwel P, Rojkind M, Unoura M, Kobayashi K, et al. Regulation of the alpha 2(I) collagen gene transcription in fat-storing cell derived from a cirrhotic liver. Hepatology. 22:1995;573-579.
111. Stefanovic B, Hellerbrand C, Holcik M, Briendl M, Aliebhaber S, Brenner DA. Posttranscriptional regulation of collagen alpha (I) mRNA in hepatic stellate cells. Mol Cell Biol. 17:1997;5201-5209.
112. Marra F, Romnelli RG, Pastacaldi S, Failli P, Pinzani M, Laffi G, et al. Monocyte chemotactic protein-1 stimulates hepatic stellate cell migration. J Hepatol. 28:1998;57. (Suppl 1).
113. Roth S, Kuhl K, Gressner AM. Subcellular localization of (latent) TGF-beta and latent TGF-beta binding protein (LTBP-1) in rat hepatocytes and hepatic stellate cells. Hepatology. 1998;. in press.
114. Potter JJ, Womack L, Mezey E, Anania FA. Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun. 244:1998;178-182.
115. Marra F, DeFranco R, Grappone C, Abboud HE. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol. 152:1998;423-430.
116. Marra F, Valente AJ, Pinzani M, Abboud HE. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest. 92:1993;1674-1680.
117. Marra F, Pastacaldi S, Romanelli RG, Pinzani M, Ticali P, Carloni V, et al. Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. FEBS Lett. 414:1997;221-225.
118. van Hogezand RA, Verspaget HW. New therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapy. Scand J Gastroenterol Suppl. 223:1997;105-107.
119. Wang SC, Tsukamoto H, Rippe RA, Schrum L, Ohata M. Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem. 273:1998;302-308.
120. Thompson KC, Trowern A, Fowell A, Marathe M, Haycock K, Arthur MJP, et al. Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin 10 during the course of activation in vitro. Hepatology. 1998;. in press.
121. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology. 24:1996;759-765.
122. Okuno M, Moriwaki H, Imai S, Muto Y, Kawada N, Suzuki Y, et al. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells [see comments]. Hepatology. 26:1997;913-921.
123. Imai S, Okuno M, Moriwaki H, Muto Y, Murakami K, Shudo K, et al. 9,13-di-cis-Retinoic acid induces the production of tPA and activation of latent TGF-beta via RAR alpha in a human liver stellate cell line, LI90. FEBS Lett. 411:1997;102-106.
124. Ohata M, Lin M, Satre M, Tsukamoto H. Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am J Physiol. 272:1997;G589-G596. (Pt 1).
125. Gottlieb TM, Oren M. p53 in growth control and neoplasia. Biochim Biophys Acta. 1287:1996;77-102.
126. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. [published erratum appears in Nat Med 1997, 3: 934] Nat Med. 3:1997;614-620.
127. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
128. Gressner AM. The cell biology of liver fibrogenesis - an imbalance of proliferation, growth arrest, and apoptosis of myofibroblasts. Cell Tissue Res. 1998;. in press.
129. Saile B, Knittel T, Matthes N, Schott P, Romadori G. CD95/Cd95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am J Pathol. 151:1997;1265-1272.
130. Gong W, Pecci A, Roth S, Lahme B, Beato M, Gressner A. Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology. 28:1998;. in press.
131. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, et al. Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. 1998;. in press.
132. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest. 94:1994;2105-2116.
133. Friedman SL. Hepatic fibrosis. Schiff E, Sorrell M, Maddrey W. 8th ed. Diseases of the Liver. 1998;Raven Press, Philadelphia. in press.
134. Shi Z, Wakil AE, Rockey DC. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA. 94:1997;10663-10668.